Macquarie Group Ltd MGL DIP HY25 Supplement

RNS Number : 6503K

Macquarie Group Ltd

01 November 2024

 

Announcement

Publication of Prospectus Supplement and Interim Financial Report

The following prospectus supplement (the Supplement) has been approved by the Financial Conduct Authority and is available for viewing:

Macquarie Group Limited (MGL) Supplement dated 1 November 2024 to the Offering Memorandum dated 7 June 2024 (the Offering Memorandum) in respect of the U.S.$20,000,000,000 MGL Debt Instrument Programme.

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6503K_1-2024-11-1.pdf

In addition, MGL has published a copy of the MGL Interim Financial Report for the Half year ended 30 September 2024 (the Interim Financial Report) on the Macquarie website at http://www.macquarie.com

 

To view the full document, please paste the following URL into the address bar of your browser:

http://www.macquarie.com/au/about/investors/reports

A copy of each of the Supplement and the Annual Report has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

 

Macquarie Group Limited 

Mr. Angus Cameron

Level 1, 1 Elizabeth Street

Sydney NSW 2000

Australia

 

Telephone: [phone]

Fax: [phone]

Email: [e-mail]

 

DISCLAIMER ‑ INTENDED ADDRESSEES

Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Offering Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Offering Memorandum, as supplemented, is not addressed.  Prior to relying on the information contained in the Offering Memorandum, as supplemented, you must ascertain from the Offering Memorandum, as supplemented, whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

PSPQKDBDDBDDDDK